Brief: Cyclo Therapeutics Announces Positive Efficacy Data From Extension Protocol With Trappsol Cyclo In Patients With Niemann-Pick Disease Type C
05/01/2021 13:27
Jan 5 (Reuters) - Cyclo Therapeutics Inc CYTH.O :
* CYCLO THERAPEUTICS ANNOUNCES POSITIVE EFFICACY DATA FROM
EXTENSION PROTOCOL WITH TRAPPSOL® CYCLO™ IN PATIENTS WITH
NIEMANN-PICK DISEASE TYPE C
Source text for Eikon: ID:nBw1bYW0Da
Further company coverage: CYTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclo Therapeutics
See all newsBrief: Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals
Cyclo Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings
U.S. STOCKS ON THE MOVE-McDonald, Uber, SolarWinds
Cyclo Therapeutics jumps on prelim late-stage data of genetic disorder drug